US LNG exports surge but will buyers in China turn up?
In a challenging economic climate, SWK Holdings Corp (SWKH) stock has touched a 52-week low, dipping to $14.45. With a market capitalization of $235.5 million and a price-to-book ratio of 0.82, InvestingPro analysis suggests the stock is currently trading below its Fair Value. Despite the broader market’s volatility, SWK Holdings has experienced a 13% increase over the past year, with particularly strong momentum shown in its YTD return of 21.2%. The company maintains robust financial health, evidenced by its impressive current ratio of 26.07 and low debt-to-equity ratio of 0.13. Investors are closely monitoring the company’s ability to maintain its upward trajectory in the face of current headwinds, as the stock’s latest dip to its annual low presents both concerns and potential opportunities for bargain-seeking shareholders. InvestingPro subscribers can access additional insights, including 5 more exclusive ProTips and a comprehensive Pro Research Report, part of the platform’s coverage of over 1,400 US equities.
In other recent news, SWK Holdings Corporation reported strong financial results for the fourth quarter of 2024, with earnings per share reaching $0.7 and net income totaling $5.9 million. The company also announced a 5% year-over-year increase in GAAP book value per share, alongside a significant revenue boost in its Mod3 Pharma division, which tripled its revenue to $3.6 million. In a strategic move, SWK Holdings completed the sale of its royalty assets for approximately $34 million to SCOF SPV I, LP, a subsidiary of Soleus Capital Management. Following this transaction, the Board of Directors declared a special cash dividend of $4.00 per share, payable to shareholders recorded as of April 24, 2025. Additionally, SWK Holdings deployed $44 million into yielding finance receivables, further enhancing its financial position. The company also discussed plans for a potential one-time special dividend and indicated that its Board may renew the share buyback program. CEO Jody Staggs expressed optimism about SWK’s future, supported by a robust life science loan portfolio and the self-sufficiency of the MOD3 CDMO division.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.